Effect of Adding PNF to IMT on Weaning Off MV (PNF/IMT/MV)

April 11, 2026 updated by: Mohammed Shaaban Attya Abd-Alhafez, Beni-Suef University

Effect of Adding Proprioceptive Neuromuscular Facilitation to Inspiratory Muscle Training on Weaning Off Mechanical Ventilation

the goal of this clinical trial is to find out the effect of adding proprioceptive neuromuscular facilitation to inspiratory muscle training on weaning off mechanical ventilation. the main question it aims to answer is is there a significant difference in the effect of inspiratory muscle training combined with PNF on the duration of weaning in the mechanically ventilated ICU patients.

researchers will compare effect of (Inspiratory muscle training combined with PNF) to (Inspiratory muscle training) and control group.

participants will be mechanically ventilated both sexes patients will be recruited in this study from intensive care unit, their ages older than 18 years. The selected patients will be mechanically ventilated due to respiratory failure and will randomly assigned into three equal groups.

Study Overview

Detailed Description

type of study: randomized control trial this study is a prospective interventional study one that will be conducted on ninety three mechanically ventilated patients with respiratory failure of both sexes their ages older than 18 years from intensive care unit and will randomly assigned into three equal groups:

  1. intervention group 1:include 31 mechanically ventilated patients will receive inspiratory muscle training along with Conventional rehabilitation program plus medical treatment.
  2. intervention group 2: include 31 mechanically ventilated patients will receive inspiratory muscle training combined with proprioceptive neuromuscular facilitation along with Conventional rehabilitation program plus medical treatment.
  3. Control group: include 31 mechanically ventilated patients will receive Conventional rehabilitation program plus medical treatment.

Instrumentations:

A) Evaluation:

All the following will be measured for all patients who will participate in this study

  1. ICU length of stay.
  2. Monitoring:

    • Mode of ventilation parameters.

      • Fiao2
      • PEEP
      • Tidal Volume
      • Respiratory Rate
    • The Duration and Type of Weaning:

      • Simple
      • Prolonged
      • Difficult
    • The patient vital signs:

      • Heart rate
      • Respiratory rate
      • Oxygen saturation
  3. Maximum inspiratory pressure
  4. Laboratory investigation:

    - Arterial Blood Gases (ABG): for measurement of Pao2, Partial pressure of CO2 (Paco2), Hco3 and PH

  5. Sonar parameters:

    - Diaphragmatic excursion.

  6. APHACH II score
  7. Shallow breathing index.
  8. Lung compliance: - Static and dynamic

Study Type

Interventional

Enrollment (Estimated)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults of both sexes
  • patients older than 18 years
  • Conscious and cooperative
  • Hemodynamic stability without significant vasopressor support.
  • No continuous sedation.
  • Mechanically ventilated due to type 1 or type 2 respiratory failure (RF) for at least 24 hours.
  • Mechanically ventilated in assisted ventilation mode
  • Are able to participate in training actively, weanable as regard shallow breathing index.
  • presence of weaning criteria as defined in the European Consensus Conference in 2007, including sedation reduction, spontaneous breathing cycles, Partial pressure of oxygen (PaO2)/ fraction of inspired oxygen (FiO2) ≥ 150, absence of inotropes or vasopressors at high doses or increasing doses (< 1 mg/h), oxy-hemoglobin saturation (SaO2) > 90% with FiO2≤ 50%, positive end expiratory pressure (PEEP) ≤ 8 cmH2O, temperature between 36 and 39 °C.

Exclusion Criteria:

  • Hemodynamic or respiratory instability
  • Condition that can compromise weaning, such as heart failure.
  • Condition that can prevent adequate performance of inspiratory muscle training, such as neuropathy or myopathy.
  • Thoracic or abdominal surgery precluding the use of PNF exercises
  • Rib fractures
  • Current pregnancy
  • Cardiac arrest with a guarded neurological prognosis
  • Deep coma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: group (A) threshold inspiratory muscle training
threshold inspiratory muscle training: threshold inspiratory muscle training in addition to conventional chest physiotherapy. The TIMT device will be connected to an endotracheal tube and will be verified to be reliable for inspiratory muscle training. With patient in 45 supine position, he will instructed to exhale slowly, empty the air in the lungs and then inhale deeply and vigorously as fast as possible. The MIP will recorded. The inspiratory resistance is set at 50% of MIP. When the heart rate, pulse oxygen, and respiratory rate are relatively stable during inspiratory training, the inspiratory resistance will be increased by 1-2 cm H2O per day. the resistance will be adjusted every day to be 50% of the new maximum inspiratory pressure then 1-2 cm H2O added. Each patient performed 6 breaths × five sets × twice daily × 5 days/ week. Until patients are weaned from mechanical ventilation.
threshold inspiratory muscle training: threshold inspiratory muscle training in addition to conventional chest physiotherapy. The TIMT device will be connected to an endotracheal tube and will be verified to be reliable for inspiratory muscle training. With patient in 45 supine position, he will instructed to exhale slowly, empty the air in the lungs and then inhale deeply and vigorously as fast as possible. The MIP will recorded. The inspiratory resistance is set at 50% of MIP. When the heart rate, pulse oxygen, and respiratory rate are relatively stable during inspiratory training, the inspiratory resistance will be increased by 1-2 cm H2O per day. the resistance will be adjusted every day to be 50% of the new maximum inspiratory pressure then 1-2 cm H2O added. Each patient performed 6 breaths × five sets × twice daily × 5 days/ week. Until patients are weaned from mechanical ventilation.
Active Comparator: group (B) PNF training + IMT
PNF training: in the form of rhythmic initiation technique (RIT) and initial stretch technique (IST) in addition to TIMT plus Conventional Chest Physiotherapy. The RIT performed to teach coordination of motion and to establish the correct breathing pattern. The IST applied to reinforce the strength of inspiratory muscles. Its main aim is to facilitate the initiation of motion . PNF techniques include two sessions per day, 5 days/week until patients are weaned from mechanical ventilation. Including four 90-second manual stimulations each (upper ribs, lower ribs, sternum, and diaphragm). After every stimulation the patient rested for one minute.
PNF training: in the form of rhythmic initiation technique (RIT) and initial stretch technique (IST) in addition to TIMT plus Conventional Chest Physiotherapy. The RIT performed to teach coordination of motion and to establish the correct breathing pattern. The IST applied to reinforce the strength of inspiratory muscles. Its main aim is to facilitate the initiation of motion . PNF techniques include two sessions per day, 5 days/week until patients are weaned from mechanical ventilation. Including four 90-second manual stimulations each (upper ribs, lower ribs, sternum, and diaphragm). After every stimulation the patient rested for one minute.
Active Comparator: group(C) Conventional Chest Physiotherapy only
Conventional Chest Physiotherapy only: two sessions per day, 5 days/week which included Vibration, Percussion, hyperinflation, and suctioning if indicated until patients are weaned from mechanical ventilation.
Conventional Chest Physiotherapy only: two sessions per day, 5 days/week which included Vibration, Percussion, hyperinflation, and suctioning if indicated until patients are weaned from mechanical ventilation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Time to Successful weaning
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)
Successful weaning: defined as sustained spontaneous breathing >48 hours post-extubation without need for reintubation or non-invasive ventilation.
From enrollment to the end of treatment (an average of 7 to 14 days)
• Maximum inspiratory pressure
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)
Maximum inspiratory pressure: to determine the inspiratory muscle strength before and after training. To measure the "negative inspiratory force" (NIF) through the ventilator settings menu (often available under "special procedures" or "lung mechanics")
From enrollment to the end of treatment (an average of 7 to 14 days)
• Diaphragmatic excursion
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)
Diaphragmatic movement is evaluated using (sonoscape sonar). The right hemidiaphragm is examined by two-dimensional (2D) and M-mode to record diaphragm excursion (displacement). The probe is placed immediately below the right costal margin in the midclavicular line in longitudinal scanning plane with the angle in cephalad direction to make the ultrasound beam perpendicular to the posterior third of the right hemidiaphragm and with the liver serving as an acoustic window.
From enrollment to the end of treatment (an average of 7 to 14 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• ICU length of stay
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)
The number of days from ICU admission to ICU discharge
From enrollment to the end of treatment (an average of 7 to 14 days)
Lung compliance
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)

Lung compliance: Calculated based on the following formula:

Static compliance=Tidal volume / plateau pressure-PEEP Dynamic compliance=Tidal volume / peak inspiratory pressure-PEEP

From enrollment to the end of treatment (an average of 7 to 14 days)
Classification of patients according to the weaning process
Time Frame: From enrollment to the end of treatment (an average of 7 to 14 days)

Into 3 Groups:

Simple weaning Patients who proceed from initiation of weaning to successful extubation on the first attempt without difficulty.

Difficult weaning Patients who fail initial weaning and require up to three SBT or as long as 7 days from the first SBT to achieve successful weaning.

Prolonged weaning Patients who fail at least three weaning attempts or require 7 days of weaning after the first SBT

From enrollment to the end of treatment (an average of 7 to 14 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sherine H Mehani, professor, Beni-Suef University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 25, 2026

Primary Completion (Estimated)

October 25, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 13, 2026

First Submitted That Met QC Criteria

April 11, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 11, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weaning From Mechanical Ventilation

Clinical Trials on threshold inspiratory muscle training + conventional chest physiotherapy

Subscribe